We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

1 hedge funds and large institutions have $3K invested in GW Pharmaceuticals Plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 294 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 297 → 1 (-296)

100% less funds holding in top 10

Funds holding in top 10: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $5.23B → $3K (-$5.23B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 294

Holders
1
Holders Change
-296
Holders Change %
-99.66%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
294
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$456M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$325M
3
HI
HBK Investments
Texas
-$292M
4
FCM
Farallon Capital Management
California
-$277M
5
GCL
Glazer Capital LLC
New York
-$212M
Name Holding Trade Value Shares
Change 		Change in
Stake
MML Investors Services
176
MML Investors Services
Massachusetts
– -$339K -1,563 Closed
Jane Street
177
Jane Street
New York
– -$329K -1,513 Closed
AAP
178
Aristotle Atlantic Partners
Florida
– -$325K -1,500 Closed
MIM
179
Meridiem Investment Management
United Kingdom
– -$325K -1,500 Closed
AWM
180
AE Wealth Management
Kansas
– -$320K -1,474 Closed
Bank of Montreal
181
Bank of Montreal
Ontario, Canada
– -$318K -1,460 Closed
BAM
182
Blueshift Asset Management
New Jersey
– -$308K -1,419 Closed
PI
183
PFS Investments
Georgia
– -$262K -1,210 Closed
LWM
184
Laidlaw Wealth Management
New York
– -$253K -1,168 Closed
PA
185
Pinnacle Associates
New York
– -$253K -1,165 Closed
CAM
186
Close Asset Management
United Kingdom
– -$250K -1,152 Closed
JMPWA
187
JP Morgan Private Wealth Advisors
California
– -$248K -1,145 Closed
UCFA
188
United Capital Financial Advisors
Texas
– -$240K -1,108 Closed
BAM
189
Belpointe Asset Management
Nevada
– -$237K -1,092 Closed
CA
190
Cetera Advisors
Colorado
– -$218K -1,006 Closed
AA
191
Ancora Advisors
Ohio
– -$217K -1,000 Closed
DekaBank Deutsche Girozentrale
192
DekaBank Deutsche Girozentrale
Germany
– -$217K -1,000 Closed
HI
193
Hoey Investments
Pennsylvania
– -$217K -1,000 Closed
PWS
194
Paragon Wealth Strategies
Florida
– -$217K -1,000 Closed
SSA
195
Schonfeld Strategic Advisors
New York
– -$217K -1,000 Closed
ET
196
Equitable Trust
Tennessee
– -$216K -996 Closed
APA
197
American Portfolios Advisors
New York
– -$212K -978 Closed
AC
198
Athanor Capital
New York
– -$211K -971 Closed
BNP Paribas Financial Markets
199
BNP Paribas Financial Markets
France
– -$206K -951 Closed
BSW
200
Buckingham Strategic Wealth
Missouri
– -$205K -946 Closed
6 7
8
9 10

GWPH Hedge Fund Activity: Q2 2021 in Review

1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2021, worth a combined $3K — down 100% from $5.23B a quarter earlier.

Sellers outnumbered buyers: 294 funds closed out of GWPH and 0 opened new positions — a net loss of 294 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pentwater Capital Management, exiting entirely with an estimated $456M sold.

  • 1 institutional investor held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2021, down from 297 in Q1 2021.
  • Funds reported $3K of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2021 and 294 closed out, a net change of -294 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2021 was Pentwater Capital Management, an estimated $456M sold.

Based on aggregated 13F filings for Q2 2021.